DHYZ can also reduce synaptic loss, antagonize Aβ-mediated nerve injury and inhibit phosphorylation of Tau protein, thereby improving the learning and memory abilities of AD mice and rats [14, 15]. Here, MAPT is linked to Alzheimer disease.